Sugi Predict

Sugi Predict / Compounds / SCHEMBL414674

SCHEMBL414674

SCHEMBL414674

[H-].c1ccc([Sn](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.38
▸ TSHR P16473 5/20 0.33
▸ TDP1 Q9NUW8 5/20 0.33
▸ ALOX12 P18054 3/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ HSD17B10 Q99714 3/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MGLL Q99685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29858810 0.96 ALDH1A1 (0.40) ALDH1A1TSHRTDP1ALOX12CA1
SCHEMBL124009 0.96 ALDH1A1 (0.40) ALDH1A1TSHRTDP1ALOX12CA1
SCHEMBL9064903 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Fluoride SCHEMBL1032387 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Iodide SCHEMBL1030211 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
SCHEMBL10938098 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Hydrochloric Acid SCHEMBL153662 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Bromide SCHEMBL1029052 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Water SCHEMBL247519 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1ALOX12CA1
Cyanide SCHEMBL9616100 0.86 ALDH1A1 (0.33) ALDH1A1TSHRTDP1ALOX12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 958 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070792-A1 METHOD FOR PRODUCING HALOTRISILANE AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICES USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-12 — — US claimed
US-20250353838-A1 METHOD FOR PREPARING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE PINOTBIO, INC. (KR) 2025-11-20 — — US claimed
EP-4524145-A1 METHOD FOR PREPARING 4?-THIO-5-AZA-2?-DEOXYCYTIDINE Pinotbio, Inc. (KR) 2025-03-19 — — EP claimed
CN-116041129-B Method for dehalogenation/deuteration of halides 吉林大学 2024-07-02 — — CN claimed
US-11906901-B2 Alternating copolymer chain scission photoresists INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2024-02-20 — — US claimed
WO-2023239190-A1 METHOD FOR PREPARING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE 주식회사 피노바이오 2023-12-14 — — WO claimed
US-20230264963-A1 METHOD FOR FABRICATING TRIHALODISILANE AND METHOD FOR FABRICATING SEMICONDUCTOR DEVICE USING THE SAME WONIK MATERIALS CO., LTD. (KR) 2023-08-24 — — US claimed
CN-116041129-A Method for dehalogenation/deuteration of halides 吉林大学 2023-05-02 — — CN claimed
EP-4108364-A1 MATERIAL SYSTEM FOR 3D PRINTING Evonik Operations GmbH (DE) 2022-12-28 — — EP claimed
CN-111129477-B Method for preparing super-assembled lithium storage material with silicon nano dots embedded in carbon skeleton 同济大学 2022-09-20 — — CN claimed
EP-0222432-A1 Bulk polymerization of dicyclopentadiene SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-05-20 — — EP claimed
EP-0102230-B1 NOVEL 6-NITROPROSTAGLANDIN DERIVATIVES, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF TEIJIN LIMITED (JP) 1987-04-29 — — EP claimed
US-4617357-A Process for reducing the content of chlorine in glycidyl compounds CIBA-GEIGY CORPORATION (US) 1986-10-14 — — US claimed
EP-0013617-B1 PENICILLIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING CERTAIN OF THESE COMPOUNDS BEECHAM GROUP PLC (GB) 1984-07-04 — — EP claimed
EP-0102230-A2 Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof TEIJIN LIMITED (JP) 1984-03-07 — — EP claimed
US-4397783-A HYDRODEHALOGENATION WITH AN ORGANOTIN HYDRIDE PFIZER INC. (US) 1983-08-09 — — US claimed
US-4347182-A Preparation of penicillanic acid derivatives BEECHAM GROUP LIMITED (GB) 1982-08-31 — — US claimed
EP-0013617-A1 Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds BEECHAM GROUP PLC (GB) 1980-07-23 — — EP claimed
US-3966713-A 11β-FLUOROANDROSTENES SCHERING AKTIENGESELLSCHAFT (DT) 1976-06-29 — — US claimed
US-3932420-A Process for the preparation of glaziovine ROUSSEL-UCLAF (FR) 1976-01-13 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353838-A1 METHOD FOR PREPARING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE DNMT1, TET1, TET3 ALDH1A1 260/4885TSHR 2416/4885TDP1 386/4885
US-20260070792-A1 METHOD FOR PRODUCING HALOTRISILANE AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICES USING THE SAME SCN1B, SCN1A, SCN2B ALDH1A1 231/4885TSHR 707/4885TDP1 1594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.